Search research articles
Contact Us
Filters
Showing results (41-50 of 72) with videos related to
Page
of 8
Sort By:
The Journal of Urology
|
April 15, 2021
Reply by Authors
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Cancer
|
March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer
Daniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology
|
January 26, 2021
Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors
Vincent T Ma, Christopher T Su, Miriam Hu, et al.
Urologic Oncology
|
December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy
Petros Grivas, Tarek A Bismar, Aijai S Alva, et al.
Cancer Research
|
August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer
Lanbo Xiao, Jean C Tien, Josh Vo, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
Cancer Research
|
December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
Andrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
The Journal of Urology
|
December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
Medical Oncology (Northwood, London, England)
|
February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome
Eman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
I Stukalin, J C Wells, J Graham, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 72) with videos related to
Sort By:
Page
of 8
The Journal of Urology
|
April 15, 2021
Reply by Authors
Kenneth J Pienta, Michael A Gorin, Steven P Rowe, et al.
Cancer
|
March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer
Daniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Urologic Oncology
|
January 26, 2021
Characterization of outcomes in patients with advanced genitourinary malignancies treated with immune checkpoint inhibitors
Vincent T Ma, Christopher T Su, Miriam Hu, et al.
Urologic Oncology
|
December 9, 2019
Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy
Petros Grivas, Tarek A Bismar, Aijai S Alva, et al.
Cancer Research
|
August 24, 2018
Epigenetic Reprogramming with Antisense Oligonucleotides Enhances the Effectiveness of Androgen Receptor Inhibition in Castration-Resistant Prostate Cancer
Lanbo Xiao, Jean C Tien, Josh Vo, et al.
Clinical Genitourinary Cancer
|
September 20, 2017
Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors
Jorge D Ramos, Jonathan T Wingate, Roman Gulati, et al.
Cancer Research
|
December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy
Andrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
The Journal of Urology
|
December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
Medical Oncology (Northwood, London, England)
|
February 15, 2021
De novo neuroendocrine transdifferentiation in primary prostate cancer-a phenotype associated with advanced clinico-pathologic features and aggressive outcome
Eman Abdulfatah, Zachery R Reichert, Matthew S Davenport, et al.
Current Oncology (Toronto, Ont.)
|
May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
I Stukalin, J C Wells, J Graham, et al.
Page
of 8